title: Reply: To PMID 23807186.
authors: *Department of Ophthalmology, Chungbuk National University, College of Medicine, Cheongju, Korea †Department of Ophthalmology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea ‡Department of Ophthalmology, University of Ulsan, College of Medicine, Gangneung Asan Hospital, Gangneung, Korea.
authors: Ju Byung
authors: JB
authors: Chae
authors: Soo Geun
authors: SG
authors: Joe
authors: Sung Jae
authors: SJ
authors: Yang
authors: Joo Yong
authors: JY
authors: Lee
authors: Kyung Rim
authors: KR
authors: Sung
authors: Jae Yong
authors: JY
authors: Kim
authors: June-Gone
authors: JG
authors: Kim
authors: Young Hee
authors: YH
authors: Yoon
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002386:Cataract / Q000150:complications*; D003930:Diabetic Retinopathy / Q000150:complications*; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000517:prevention & control*; D008297:Male; D018918:Phacoemulsification; D011183:Postoperative Complications
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized